E
LLY icon

Ergoteles’s Eli Lilly LLY Stock Holding History

Ergoteles’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,425
Closed -$1.86M – 1288
2023
Q1 		$1.86M Buy
5,425
+621
+13% +$209K 0.07% 293
2022
Q4 		$1.76M Sell
4,804
-2,312
-32% -$820K 0.06% 307
2022
Q3 		$2.3M Buy
+7,116
New +$2.25M 0.08% 245
2021
Q3 		– Sell
-41,681
Closed -$9.57M – 1477
2021
Q2 		$9.57M Buy
+41,681
New +$8.37M 0.22% 138
2021
Q1 		– Sell
-30,346
Closed -$5.12M – 943
2020
Q4 		$5.12M Sell
30,346
-133,554
-81% -$19.9M 0.17% 134
2020
Q3 		$24.3M Buy
+163,900
New +$25.4M 3.21% 5

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Ergoteles's LLY Position: Q2 2023 in Review

Ergoteles sold out of Eli Lilly (LLY) in Q2 2023, closing a stake of 5,425 shares — an estimated $1.86M sold.

Ergoteles first reported a position in LLY in Q3 2020 and held it in 6 quarters. The position peaked at $24.3M in Q3 2020. 2,814 funds tracked by Wall St. Rank hold LLY as of Q2 2023.

  • Ergoteles reported no remaining Eli Lilly position as of Q2 2023 after selling out during the quarter.
  • Ergoteles sold 5,425 Eli Lilly shares in Q2 2023, an estimated $1.86M.
  • Ergoteles first reported a position in Eli Lilly in Q3 2020 and held it in 6 quarters.
  • Ergoteles's Eli Lilly position peaked at $24.3M in Q3 2020.
  • 2,814 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2023.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.